ALEX BRUMMER: Glaxo looks to a post-Covid, post-Brexit future
Despite its amazing vaccine credentials, GlaxoSmithKline has not had a good war against Covid-19. It has been disappointing for chief executive Emma Walmsley that results from its collaboration with France’s Sanofi have fallen way behind, and it has dropped a partnership with China’s Clover. No one can accuse GSK of despairing. Along with its pre-tax … Read more